Literature DB >> 15227481

Tricuspid atresia associated with double-orifice mitral valve and coronary sinus septal defect.

I S Park1, S J Yoo, K S Kim, C Y Hong.   

Abstract

Clinical, echocardiographic, and angiographic findings of a very rare case of cardiac malformation are presented. The main features were tricuspid atresia, coronary sinus septal defect, and double-orifice mitral valve. These defects were correctly diagnosed by echocardiography and were confirmed by angiocardiography.

Entities:  

Year:  1991        PMID: 15227481      PMCID: PMC324998     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  5 in total

1.  Severe mitral regurgitation in a woman with a double orifice mitral valve.

Authors:  J Kron; R J Standerfer; A Starr
Journal:  Br Heart J       Date:  1986-01

2.  Subxiphoid two-dimensional echocardiographic diagnosis of coronary sinus septal defects.

Authors:  S B Yeager; A J Chin; S P Sanders
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

3.  Tricuspid atresia with double-outlet left atrium.

Authors:  R M Bini; P A Pellegrino; A Mazzucco; V Gallucci; O Milanesi; F Maddalena; G Thiene
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

4.  Two-dimensional echocardiographic findings in double orifice mitral valve.

Authors:  E Trowitzsch; A Bano-Rodrigo; B M Burger; S D Colan; S P Sanders
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

Review 5.  Double-orifice mitral valve: a study of 27 postmortem cases with developmental, diagnostic and surgical considerations.

Authors:  A Baño-Rodrigo; S Van Praagh; E Trowitzsch; R Van Praagh
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

  5 in total
  1 in total

1.  Double Orifice Mitral Valve in Tricuspid Atresia: A Rare Association.

Authors:  Massimiliano Cantinotti; Raffaele Giordano; Chiara Marrone; Eliana Franchi; Martin Koestenberger; Nadia Assanta
Journal:  Pediatr Cardiol       Date:  2019-09-10       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.